A recent study reported that TFEB overexpression in another AD mouse model is responsible for a reduction of the levels of the β-secretase-derived β-amyloid precursor protein fragment C99, which is a precursor of the toxic Aβ peptide. Here, TFEB is linked to Alzheimer disease.